Latest ophthalmic solution Stories
IRVINE, Calif., June 7, 2011 /PRNewswire/ -- Allergan, Inc. (NYSE: AGN), the maker of LATISSEÂ® (bimatoprost ophthalmic solution) 0.03%, announced today the launch of the 2011 LATISSEÂ® Wishes Challenge.
FDC has received approval from the FDA for its abbreviated new drug application, Ciprofloxacin ophthalmic solution. FDC's Ciprofloxacin Ophthalmic Solution is a broad spectrum antibiotic used for occular surface infections.
- The abrogation of a law by a higher authority; annulment.